Finance

Lists
688606:SHA
Hangzhou Alltest Biotech Co Ltd
CN¥46.30
-1.03%
(-0.48) 1D
Oct 16, 3:00:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688606...
Open
CN¥46.85
High
CN¥48.57
Low
CN¥46.08
Mkt. cap
3.69B
Avg. vol.
321.14K
Volume
461.81K
Dividend
4.32%
Quarterly dividend
CN¥0.50
Ex-dividend date
Jun 1, 2026
P/E ratio
26.49
52-wk high
CN¥72.88
52-wk low
CN¥39.80
EPS
CN¥1.75
No. of employees
960
Open
CN¥46.85
High
CN¥48.57
Low
CN¥46.08
Mkt. cap
3.69B
Avg. vol.
321.14K
Volume
461.81K
Dividend
4.32%
Quarterly dividend
CN¥0.50
Ex-dividend date
Jun 1, 2026
P/E ratio
26.49
52-wk high
CN¥72.88
52-wk low
CN¥39.80
EPS
CN¥1.75
No. of employees
960
News stories
From web sources and news partners
About Hangzhou Alltest Biotech Co Ltd
CEO-
Employees960
FoundedApr 17, 2009
Headquarters-
SectorMedical device
Websitealltests.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
203.23M
272.27M
195.37M
196.77M
Cost of goods sold
89.68M
171.15M
91.99M
92.97M
Cost of revenue
89.68M
171.15M
91.99M
92.97M
Research and development expenses
26.02M
35.10M
28.75M
31.64M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
41.16M
44.86M
36.47M
33.87M
Operating expense
47.19M
103.62M
73.22M
70.60M
Total operating expenses
136.87M
274.76M
165.21M
163.57M
Operating income
66.36M
-2.49M
30.17M
33.20M
Other non operating income
-4.55M
3.58M
-19.03M
18.08M
EBT including unusual items
66.14M
32.93M
21.76M
32.26M
EBT excluding unusual items
68.37M
-12.92M
16.13M
27.49M
Income tax expense
8.52M
2.58M
2.63M
751.83K
Effective tax rate
12.88%
7.84%
12.08%
2.33%
Other operating expenses
-22.23M
27.73M
4.68M
5.77M
Net income
57.80M
30.38M
19.39M
31.45M
Net profit margin
28.44%
11.16%
9.93%
15.98%
Earnings per share
-
-
-
-
Interest and investment income
7.19M
-
5.20M
8.32M
Interest expense
-147.09K
-1.06M
-206.80K
-
Net interest expenses
7.05M
-1.06M
5.00M
8.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
72.82M
7.39M
40.05M
44.32M
Gain or loss from assets sale
-
-616.68K
-
-65.17K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps